LOADING
Comparing JPMorgan Chase (JPM) and Thermo Fisher Scientific (TMO) across the Financials and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | JPM | TMO |
|---|---|---|
| Price | $294.60 | $491.46 |
| Change Today | -0.26% | -0.62% |
| Market Cap | $794.5B | $182.6B |
| P/E Ratio | 14.7 | 27.7 |
| Forward P/E | 13.7 | 19.8 |
| PEG Ratio | 1.65 | 1.82 |
| EPS | $20.03 | $17.74 |
| Revenue Growth (YoY) | 2.5% | 7.2% |
| Profit Margin | 33.9% | 15.0% |
| Return on Equity | 16.1% | 13.0% |
| Dividend Yield | 1.96% | 0.35% |
| Beta | 1.04 | 0.97 |
| 52-Week High | $335.87 | $643.35 |
| 52-Week Low | $199.32 | $384.44 |
| Volume | 6.7M | 1.7M |
JPMorgan Chase is the larger company by market capitalization. JPMorgan Chase trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. JPMorgan Chase offers a higher dividend yield for income investors. JPMorgan Chase has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.